CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
Vision loss due to Glaucoma can be prevented if it is detected and treated early
Women emerge as the cornerstone of this monumental undertaking
The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation
These approvals mark significant progress for Venus Remedies in expanding its market presence
The validations confirm the completion of the applications and commence the scientific review process
The facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Neurontin Tablets, 600 mg and 800 mg, of Viatris Specialty
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
Acquisition of exclusive commercialization rights for European markets
Subscribe To Our Newsletter & Stay Updated
